PerkinElmer to Display Portfolio of Cancer Research Technologies and Workflow Solutions at 2017 AACR Annual Meeting
Download PDF Read more
Category: Clinical Research/Diagn.
Fabric Genomics and Sentieon Sign Strategic Partnership to Bring Advanced Genomic Analysis Capabilities to the Clinical Market
Technology Collaboration to Power Fabric StandardTM, the Fastest and Most Accurate Secondary Analysis Solution Available March 21, 2017 06:00 AM Pacific Daylight Time OAKLAND, Calif. & MOUNTAIN VIEW, Calif. & PHOENIX–(BUSINESS WIRE)–Fabric Genomics, a global computational genomics company, and Sentieon, which develops highly optimized algorithms for bioinformatics applications, today announced a technology partnership that will enhance... Read more
SCIEX and the Children’s Medical Research Institute Announce Opening of ProCan to Advance Precision Medicine
SCIEX industrialised proteomics solutions, using microflow SWATH® Acquisition, will accelerate cancer research March 21, 2017 Framingham, MA U.S.A. and Sydney, Australia — SCIEX, a global leader in life science analytical technologies, has announced that Children’s Medical Research Institute (CMRI) has opened ProCan™, the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer.... Read more
Agilent Technologies Enhances Exome Sequencing for Clinical Research
New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif., March 21, 2017 Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the... Read more
Thermo Fisher Scientific and the Cell and Gene Therapy Catapult Collaborate to Optimise Advanced Therapy Supply Chain
LONDON–(BUSINESS WIRE)–To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult) to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed... Read more
New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease
CARLSBAD, Calif. & PHOENIX–(BUSINESS WIRE)–A new high-throughput, microarray-based assay designed to detect more than 6,000 genomic variations associated with inherited disease now provides molecular genetics laboratories with a consolidated and automated, single pan-ethnic solution for expanded carrier status research. Thermo Fisher Scientific announced the CarrierScan™ Assay today at the 2017 ACMG Annual Clinical Genetics Meeting... Read more
Beckman Coulter Diagnostics Receives FDA Clearance for its DxC 700 AU Chemistry Analyzer
New system helps meet increasing demands for larger test volumes and reduces total cost of ownership for hospital laboratories and integrated delivery networks BREA, Calif., March 7, 2017 /PRNewswire/ — Beckman Coulter Diagnostics announces FDA clearance and U.S. commercial launch of its new DxC 700 AU chemistry analyzer. The new system brings together the advanced capabilities... Read more
Agilent Technologies Introduces Postnatal Assay for Detection of Genetic Anomalies
GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster SANTA CLARA, Calif., March 2, 2017 Agilent Technologies Inc. (NYSE: A) has introduced its first comparative genomic hybridization (CGH) assay for diagnostic use: the GenetiSure Dx Postnatal Assay. This assay will enable clinical geneticists to detect genetic anomalies earlier and more accurately... Read more
Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business
CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series B... Read more
Seegene Develops New Normalization Software Technology for Molecular Diagnosis
14 Feb, 2017, 09:00 ET SEOUL, South Korea, Feb. 14, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies today announced that it has developed a new software technology that can normalize test results of real-time PCR molecular diagnosis systems. This new innovative technology calibrates test results by correcting signal variations... Read more